{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_198578.4:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S"
        },
        {
          "HGVS": "NM_198578.4:c.6059T>C",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "T",
            "alt": "C",
            "position": "6059"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "2020"
          },
          "Description in input context": "I2020T"
        },
        {
          "HGVS": "NM_198578.4:c.4321C>T",
          "cDNA Change": {
            "transcript": "NM_198578.4",
            "ref": "C",
            "alt": "T",
            "position": "4321"
          },
          "Protein Change": {
            "ref": "R",
            "alt": "C",
            "position": "1441"
          },
          "Description in input context": "R1441C"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson Disease",
    "MONDO": "MONDO:0005180"
  },
  "Experiment Method": [
    {
      "Assay Method": "In Vitro Kinase Assay",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "SF-TAP tagged LRRK2 variants were expressed in HEK293 cells and purified via SF-TAP tandem affinity purification."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2 G2019S shows a 3-4-fold increase in kinase activity towards MKK6 compared to wild-type LRRK2."
        },
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "LRRK2 I2020T shows a slight but significant increase (1.5-fold) in kinase activity towards MKK6 compared to wild-type LRRK2."
        },
        {
          "Variant": "NM_198578.4:c.4321C>T",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "LRRK2 R1441C shows no significant alteration in kinase activity towards MKK6 compared to wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each aliquot of LRRK2 was divided into three to four sub-aliquots prior to kinase assay."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control for kinase activity comparison."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Kinase dead variant LRRK2 K1906M was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Analysis of variance (ANOVA) was used, with pair-wise comparison performed by Tukey's post-hoc test."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels equivalent to wild-type LRRK2 activity (set as 100%).",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels significantly higher or lower than wild-type LRRK2 activity (e.g., >150% or <50%).",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Western Blotting",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "Proteins from kinase assays using HEK293-derived LRRK2 variants were separated and blotted for analysis."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Western blot analysis confirmed increased phosphorylation of MKK substrates by LRRK2 G2019S."
        },
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Western blot analysis confirmed a slight increase in phosphorylation of MKK substrates by LRRK2 I2020T."
        },
        {
          "Variant": "NM_198578.4:c.4321C>T",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Western blot analysis showed no significant change in phosphorylation of MKK substrates by LRRK2 R1441C."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Kinase dead variants were used as negative controls in Western blot analysis."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Densitometric analysis was performed using Image Quant software."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation signal intensity equivalent to wild-type LRRK2.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation signal intensity significantly higher or lower than wild-type LRRK2.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Homology Modelling",
      "Material used": {
        "Material Source": "In Silico",
        "Material Name": "LRRK2 Kinase Domain",
        "Description": "Structures of the LRRK2 kinase domain and PD-associated variants were modelled using the swiss-model server with TAB1 structure as a template."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_198578.4:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Homology modelling revealed that the G2019S mutation causes a local perturbation in the backbone structure of the LRRK2 kinase domain, likely facilitating an active kinase conformation."
        },
        {
          "Variant": "NM_198578.4:c.6059T>C",
          "Conclusion": "Normal",
          "Molecular Effect": "No Effect",
          "Result Description": "Homology modelling showed no predictable effect on the backbone conformation for the I2020T mutation."
        },
        {
          "Variant": "NM_198578.4:c.4321C>T",
          "Conclusion": "N.D.",
          "Molecular Effect": "N.D.",
          "Result Description": "Homology modelling was not specifically performed for the R1441C mutation in the context of kinase domain structure."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not applicable for in silico analysis."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not applicable for in silico analysis."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not applicable for in silico analysis."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not applicable for in silico analysis."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "Not applicable for homology modelling."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Structural conformation similar to wild-type LRRK2 kinase domain.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Significant structural deviation from wild-type LRRK2 kinase domain.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}